Medtronic (NYSE:MDT) has received FDA 510(k) clearance for its Nellcor pulse oximetry system with the Nell-EQ intelligent ...

The Nell-EQ™ intelligent processor is a new pulse oximetry processing technology designed to support more consistent and ...

Medtronic has received Food and Drug Administration clearance for an updated version of its Nellcor pulse oximetry system.

January 22, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced verification study results for its investigational Nellcor™ pulse oximetry with Nell-EQ™ intelligent processor ...

Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced the integration of its Nellcor™ OxiMax™ oximetry system into Philips IntelliVue and M-Series patient monitors.

Covidien has announced the launch of its Nellcor SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform, according to a news release. The Nellcor SpO2 module ...

Across the healthcare landscape, more and more conversations are focusing on health inequity. Specific to pulse oximetry, recent research, media, and regulatory discussions have been raising awareness ...

Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...

This regulatory milestone follows news from earlier this year, when the company announced positive verification study results ...

This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor ...